Drug Shortage Report for BRAVELLE
Report ID | 802 |
Drug Identification Number | 02268140 |
Brand name | BRAVELLE |
Common or Proper name | BRAVELLE |
Company Name | FERRING INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | Urofollitropin for injection |
Strength(s) | 75 IU's per vial |
Dosage form(s) | Powder for Injection |
Route of administration | Subcutaneous |
Packaging size | 5 vials |
ATC code | G03GA |
ATC description | GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2015-09-09 |
Actual start date | 2015-10-01 |
Estimated end date | Unknown |
Actual end date | 2019-07-18 |
Shortage status | Resolved |
Updated date | 2019-07-29 |
Company comments | Product has been discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2019-07-29 | French | Compare |
v14 | 2019-07-29 | English | Compare |
v13 | 2019-01-10 | French | Compare |
v12 | 2019-01-10 | English | Compare |
v11 | 2018-07-16 | French | Compare |
v10 | 2018-07-16 | English | Compare |
v9 | 2018-03-15 | French | Compare |
v8 | 2018-03-15 | English | Compare |
v7 | 2018-01-09 | French | Compare |
v6 | 2018-01-09 | English | Compare |
v5 | 2017-10-06 | English | Compare |
v4 | 2017-10-06 | English | Compare |
v3 | 2017-03-13 | French | Compare |
v2 | 2017-03-13 | English | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 15 of 15